High efficiency particulate air cleaner intervention to reduce respiratory virus exposure in elementary schools

高效颗粒空气净化器干预减少小学呼吸道病毒暴露

基本信息

  • 批准号:
    10722583
  • 负责人:
  • 金额:
    $ 27.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-07-10 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT There is a fundamental gap in understanding the extent to which the school environment contributes to respiratory virus exposure, and less is known about effective environmental interventions to reduce exposure. Our long-term goal is to create healthy indoor school environments for children. The overall objective of this application is to identify environmental predictors of and potential interventions influencing respiratory virus exposure in elementary schools. We will extend the robust infrastructure of the School Inner-City Asthma Intervention Study (SICAS-2, ClinicalTrials.gov NCT02291302), a five-year randomized controlled trial conducted by our group of a placebo-controlled classroom high efficiency particulate air (HEPA) cleaner intervention to continue cohort recruitment in the post-COVID-19 pandemic period. We will test our central hypothesis that modifiable built environment factors influence airborne respiratory virus exposure and infection in elementary schools through the following specific aims: (1) To determine the efficacy of a randomized placebo controlled HEPA cleaner intervention in reducing classroom airborne respiratory virus exposure; (2) To determine the efficacy of a randomized placebo controlled HEPA cleaner intervention in reducing symptomatic and asymptomatic respiratory viral infections in asthmatic children. The approach is innovative, because we are simultaneously interrogating all major human respiratory viruses in the context of a school-based randomized trial focused on an environmental intervention. The proposed research is significant, because if the HEPA intervention can reduce respiratory virus exposure and infections in schools, it is an immediately actionable and practical intervention to create safer indoor environments for elementary school children. Results from this proposal may be generalizable to other public indoor settings.
项目摘要/摘要 在理解学校环境在多大程度上有助于 与呼吸道病毒接触有关,对减少接触的有效环境干预知之甚少。 我们的长期目标是为孩子们创造健康的室内学校环境。这样做的总体目标是 应用是确定影响呼吸道病毒的环境预测因素和潜在干预措施 在小学中的暴露。我们将扩展市中心哮喘学校强大的基础设施 干预研究(SICAS-2,ClinicalTrials.gov NCT02291302),一项为期五年的随机对照试验 由我们一组安慰剂控制的教室高效颗粒物空气净化器进行 干预措施,以在新冠肺炎大流行后继续招募队列。我们将测试我们的中央 可改变的建筑环境因素影响空气传播呼吸道病毒暴露和感染的假说 在小学通过以下具体目标:(1)确定随机化的效果 安慰剂对照HEPA清洁剂干预减少教室空气传播呼吸道病毒暴露;(2) 确定随机安慰剂对照的HEPA清洁剂干预在减少症状方面的有效性 以及哮喘儿童的无症状呼吸道病毒感染。这种方法是创新的,因为我们 同时在一所学校的背景下审问所有主要的人类呼吸道病毒 随机试验的重点是环境干预。这项拟议的研究意义重大,因为如果 HEPA干预可以减少呼吸道病毒在学校的暴露和感染,这是一个即时的 采取切实可行的干预措施,为小学生创造更安全的室内环境。 这一建议的结果可以推广到其他公共室内环境。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peggy Sue Lai其他文献

Peggy Sue Lai的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peggy Sue Lai', 18)}}的其他基金

Molecular epidemiology of respiratory virus exposure in elementary schools
小学呼吸道病毒暴露的分子流行病学
  • 批准号:
    10646577
  • 财政年份:
    2023
  • 资助金额:
    $ 27.49万
  • 项目类别:
The school microbiome and asthma morbidity in inner-city children
内城区儿童的学校微生物组和哮喘发病率
  • 批准号:
    10065492
  • 财政年份:
    2019
  • 资助金额:
    $ 27.49万
  • 项目类别:
The school microbiome and asthma morbidity in inner-city children
内城区儿童的学校微生物组和哮喘发病率
  • 批准号:
    10541838
  • 财政年份:
    2019
  • 资助金额:
    $ 27.49万
  • 项目类别:
The school microbiome and asthma morbidity in inner-city children
内城区儿童的学校微生物组和哮喘发病率
  • 批准号:
    10317083
  • 财政年份:
    2019
  • 资助金额:
    $ 27.49万
  • 项目类别:
Endotoxin, the airway transcriptome, and obstructive lung disease
内毒素、气道转录组和阻塞性肺病
  • 批准号:
    9066670
  • 财政年份:
    2013
  • 资助金额:
    $ 27.49万
  • 项目类别:
Endotoxin, the airway transcriptome, and obstructive lung disease
内毒素、气道转录组和阻塞性肺病
  • 批准号:
    8852128
  • 财政年份:
    2013
  • 资助金额:
    $ 27.49万
  • 项目类别:
Endotoxin, the airway transcriptome, and obstructive lung disease
内毒素、气道转录组和阻塞性肺病
  • 批准号:
    8739644
  • 财政年份:
    2013
  • 资助金额:
    $ 27.49万
  • 项目类别:
Endotoxin, the airway transcriptome, and obstructive lung disease
内毒素、气道转录组和阻塞性肺病
  • 批准号:
    8617465
  • 财政年份:
    2013
  • 资助金额:
    $ 27.49万
  • 项目类别:
Lung disease due to chronic endotoxin exposure in mouse and human models
小鼠和人类模型中慢性内毒素暴露引起的肺部疾病
  • 批准号:
    8608942
  • 财政年份:
    2012
  • 资助金额:
    $ 27.49万
  • 项目类别:
Lung disease due to chronic endotoxin exposure in mouse and human models
小鼠和人类模型中慢性内毒素暴露引起的肺部疾病
  • 批准号:
    8252322
  • 财政年份:
    2012
  • 资助金额:
    $ 27.49万
  • 项目类别:

相似海外基金

I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 27.49万
  • 项目类别:
    Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 27.49万
  • 项目类别:
    Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 27.49万
  • 项目类别:
    Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 27.49万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 27.49万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 27.49万
  • 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 27.49万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 27.49万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 27.49万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 27.49万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了